"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A,US 3492202 A,120-594-296-516-657,1970-01-27,1970,US 3492202D A,1967-12-12,US 68977267 A,1967-12-12,PROCESS FOR THE PRODUCTION OF BETA-CAROTENE,,PFIZER & CO C,BOHINSKI ROBERT C,,https://lens.org/120-594-296-516-657,Granted Patent,no,1,7,2,2,0,C12P23/00;;Y10S435/911;;C12P23/00;;Y10S435/911,C12P23/00,195/28,0,0,,,,EXPIRED
2,CA,A1,CA 2188157 A1,092-346-441-740-668,1995-11-23,1995,CA 2188157 A,1995-05-17,US 24535694 A,1994-05-18,NUCLEIC ACID SEQUENCES CONTROLLING LUNG CELL-SPECIFIC GENE EXPRESSION,"An oligonucleotide which includes at least one nucleic acid sequence which binds to at least one nuclear protein found in lung cells, such as TTF-1 protein. The oligonucleotide may be contained in a vector. The at least one nuclear protein provides for lung cell-specific expression of the vector upon binding of the at least one nucleic acid sequence to the at least one nuclear protein. Such vector may also include genes encoding therapeutic agents, and may be employed for delivering genes encoding therapeutic agents to lung cells.",CHILDRENS HOSP MEDICAL CENTER,BOHINSKI ROBERT J;;WHITSETT JEFFREY A,,https://lens.org/092-346-441-740-668,Patent Application,no,0,0,7,7,0,A61K48/00;;C07K14/4705;;C07K14/785;;C12N15/85;;C12N15/86;;C12N2710/10343;;C12N2830/00;;C12N2830/008;;C12N2830/85;;Y10T428/2984;;Y10T428/2984;;C12N15/86;;C12N2830/008;;C12N2830/85;;A61K48/00;;C12N15/85;;C12N2710/10343;;C12N2830/00;;C07K14/785;;C07K14/4705,G01N33/566;;A61K48/00;;C07H21/04;;C07K14/47;;C07K14/785;;C12N15/00;;C12N15/09;;C12N15/85;;C12N15/861;;C12Q1/68;;C12R1/92,,0,0,,,,DISCONTINUED
3,US,A1,US 2001/0016352 A1,039-354-533-060-852,2001-08-23,2001,US 32033799 A,1999-05-26,US 32033799 A;;US 44280995 A;;US 24535694 A,1994-05-18,NUCLEIC ACID SEQUENCES CONTROLLING LUNG CELL-SPECIFIC GENE EXPRESSION,"
   An oligonucleotide which includes at least one nucleic acid sequence which binds to at least one nuclear protein found in lung cells, such as TTF-1 protein. The oligonucleotide may be contained in a vector. The at least one nuclear protein provides for lung cell-specific expression of the vector upon binding of the at least one nucleic acid sequence to the at least one nuclear protein. Such vector may also include genes encoding therapeutic agents, and may be employed for delivering genes encoding therapeutic agents to lung cells. 
",BOHINSKI ROBERT J.;;WHITSETT JEFFREY A.,BOHINSKI ROBERT J;;WHITSETT JEFFREY A,,https://lens.org/039-354-533-060-852,Patent Application,yes,0,5,7,7,0,A61K48/00;;C07K14/4705;;C07K14/785;;C12N15/85;;C12N15/86;;C12N2710/10343;;C12N2830/00;;C12N2830/008;;C12N2830/85;;Y10T428/2984;;Y10T428/2984;;C12N15/86;;C12N2830/008;;C12N2830/85;;A61K48/00;;C12N15/85;;C12N2710/10343;;C12N2830/00;;C07K14/785;;C07K14/4705,A61K48/00;;C07H21/04;;C07K14/47;;G01N33/566;;C07K14/785;;C12N15/00;;C12N15/09;;C12N15/85;;C12N15/861;;C12Q1/68;;C12R1/92,435/320.1;;536/23.1;;514/2,0,0,,,,DISCONTINUED
4,WO,A1,WO 1995/031729 A1,140-054-705-983-976,1995-11-23,1995,US 9506244 W,1995-05-17,US 24535694 A,1994-05-18,NUCLEIC ACID SEQUENCES CONTROLLING LUNG CELL-SPECIFIC GENE EXPRESSION,"An oligonucleotide which includes at least one nucleic acid sequence which binds to at least one nuclear protein found in lung cells, such as TTF-1 protein. The oligonucleotide may be contained in a vector. The at least one nuclear protein provides for lung cell-specific expression of the vector upon binding of the at least one nucleic acid sequence to the at least one nuclear protein. Such vector may also include genes encoding therapeutic agents, and may be employed for delivering genes encoding therapeutic agents to lung cells.",CHILDRENS HOSP MEDICAL CENTER,BOHINSKI ROBERT J;;WHITSETT JEFFREY A,,https://lens.org/140-054-705-983-976,Patent Application,yes,1,0,7,7,0,A61K48/00;;C07K14/4705;;C07K14/785;;C12N15/85;;C12N15/86;;C12N2710/10343;;C12N2830/00;;C12N2830/008;;C12N2830/85;;Y10T428/2984;;Y10T428/2984;;C12N15/86;;C12N2830/008;;C12N2830/85;;A61K48/00;;C12N15/85;;C12N2710/10343;;C12N2830/00;;C07K14/785;;C07K14/4705,A61K48/00;;C07H21/04;;C07K14/47;;C07K14/785;;C12N15/00;;C12N15/09;;G01N33/566;;C12N15/85;;C12N15/861;;C12Q1/68;;C12R1/92,,12,10,043-156-374-114-741;;064-173-215-963-160;;022-490-954-163-445;;018-096-680-842-036;;055-458-762-388-794;;127-486-074-425-123;;055-290-832-933-553;;063-469-288-339-138;;005-644-090-005-687;;000-915-229-708-783,10.1016/s0021-9258(18)82105-6;;8496176;;3338020;;10.1002/1097-0142(19880201)61:3<532::aid-cncr2820610319>3.0.co;2-8;;10.1042/bj2950227;;pmc1134843;;8216221;;pmc359916;;10.1128/mcb.13.7.3860-3871.1993;;8321193;;10.1128/mcb.13.7.3860;;10.1016/s0021-9258(18)45836-x;;2254341;;3502707;;pmc254146;;10.1128/jvi.61.5.1639-1646.1987;;pmc282234;;10.1073/pnas.85.20.7572;;2845412;;1370653;;10.1016/0092-8674(92)90213-v;;10.1128/mcb.12.2.576-588.1992;;pmc364231;;10.1128/mcb.12.2.576;;1732732;;10.1128/mcb.13.4.2401;;8455618;;10.1128/mcb.13.4.2401-2410.1993;;pmc359561,"THE JOURNAL OF BIOLOGICAL CHEMISTRY, Volume 268, Number 15, issued 25 May 1993, BOHINSKI et al., ""Cis-Active Elements Controlling Lung Cell-Specific Expression of Human Pulmonary Surfactant Protein B Gene"", pages 11160-11166.;;JOURNAL OF CELLULAR BIOCHEMISTRY, Supplement 17E, issued 29 March 25 April 1993, D'AMORE-BRUNO et al., ""Therapeutic Strategies for Surfactant Protein SP-B Deficiency"", page 241, Abstract Number SZ400.;;CANCER, Volume 61, Number 3, issued 01 February 1988, MIZUTANI et al., ""Immunohistochemical Localization of Pulmonary Surfactant Apoproteins in Various Lung Tumors"", pages 532-537.;;BIOCHEMICAL JOURNAL, Volume 295, issued 1993, BINGLE et al., ""Identification of Hepatocyte Nuclear Factor-3 Binding Sites in the Clara Cell Secretory Protein Gene"", pages 227-232.;;MOLECULAR AND CELLULAR BIOLOGY, Volume 13, Number 7, issued July 1993, SAWAYA et al., ""The Lung-Specific CC10 Gene is Regulated by Transcription Factors from the AP-1, Octamer and Hepatocyte Nuclear Factor 3 Families"", pages 3860-3871.;;THE JOURNAL OF BIOLOGICAL CHEMISTRY, Volume 265, Number 35, issued 15 December 1990, GLASSER et al., ""Structure and Expression of the Pulmonary Surfactant Protein SP-C Gene in the Mouse"", pages 21986-21991.;;JOURNAL OF VIROLOGY, Volume 61, Number 5, issued May 1987, BENDER et al., ""Evidence that the Packaging Signal of Moloney Murine Leukemia Virus Extends Into the Gag Region"", pages 1639-1646.;;PROC. NATL. ACAD. SCI. U.S.A., Volume 85, issued October 1988, BORRELLI et al., ""Targeting of an Inducible Toxic Phenotype in Animal Cells"", pages 7572-7576.;;CELL, Volume 68, issued 10 January 1992, ROSENFELD et al., ""In Vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to the Airway Epithelium"", pages 143-155.;;MOLECULAR AND CELLULAR BIOLOGY, Volume 12, Number 2, issued February 1992, FRANCIS-LANG et al., ""Cell-Type-Specific Expression of the Rat Thyroperoxidase Promotor Indicates Common Mechanisms for Thyroid-Specific Gene Expression"", pages 576-588.;;MOLECULAR AND CELLULAR BIOLOGY, Volume 13, Number 4, issued April 1993, JACKSON et al., ""Modulation of Liver-Specific Transcription by Interactions Between Hepatocyte Nuclear Factor 3 and Nuclear Factor 1 Binding DNA in Close Apposition"", pages 2401-2410.;;See also references of EP 0763205A4",PENDING
5,EP,A4,EP 0763205 A4,192-603-915-057-714,1999-07-21,1999,EP 95921285 A,1995-05-17,US 9506244 W;;US 24535694 A,1994-05-18,NUCLEIC ACID SEQUENCES CONTROLLING LUNG CELL-SPECIFIC GENE EXPRESSION,,CHILDRENS HOSP MEDICAL CENTER,BOHINSKI ROBERT J;;WHITSETT JEFFREY A,,https://lens.org/192-603-915-057-714,Search Report,no,0,0,7,7,0,A61K48/00;;C07K14/4705;;C07K14/785;;C12N15/85;;C12N15/86;;C12N2710/10343;;C12N2830/00;;C12N2830/008;;C12N2830/85;;Y10T428/2984;;Y10T428/2984;;C12N15/86;;C12N2830/008;;C12N2830/85;;A61K48/00;;C12N15/85;;C12N2710/10343;;C12N2830/00;;C07K14/785;;C07K14/4705,A61K48/00;;C07H21/04;;C07K14/47;;C07K14/785;;C12N15/00;;C12N15/09;;G01N33/566;;C12N15/85;;C12N15/861;;C12Q1/68;;C12R1/92,,10,8,008-226-824-553-787;;065-397-502-241-573;;036-939-024-159-47X;;025-508-408-776-799;;111-551-278-714-039;;005-686-525-813-161;;068-246-306-395-824;;104-403-911-478-812,7713914;;10.1074/jbc.270.14.8108;;10.1074/jbc.270.12.6531;;7896788;;10.1128/mcb.14.9.5671;;10.1128/mcb.14.9.5671-5681.1994;;pmc359092;;8065304;;1811929;;10.1242/dev.113.4.1093;;1976511;;10.1002/j.1460-2075.1990.tb07574.x;;pmc552115;;10.1016/0303-7207(95)03589-y;;7589789;;7711080;;10.1016/0167-4781(95)00034-e;;7711079;;10.1016/0167-4781(95)00033-d,"IKEDA K ET AL: ""Gene structure and expression of human thyroid transcription factor - 1 in respiratory epithelial cells."", JOURNAL OF BIOLOGICAL CHEMISTRY, (1995 APR 7) 270 (14) 8108-14. JOURNAL CODE: HIV. ISSN: 0021-9258., United States, XP002096750;;BRUNO M D ET AL: ""Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor - 1 [published erratum appears in J Biol Chem 1995 Jul 7;270(27):16482]."", JOURNAL OF BIOLOGICAL CHEMISTRY, (1995 MAR 24) 270 (12) 6531-6. JOURNAL CODE: HIV. ISSN: 0021-9258., United States, XP002096751;;BOHINSKI, ROBERT J. ET AL: ""The lung -specific surfactant protein B gene promoter is a targe for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis."", MOLECULAR AND CELLULAR BIOLOGY, (1994) VOL. 14, NO. 9, PP. 5671-5681. ISSN: 0270-7306., XP002096752;;LAZZARO D ET AL: ""The transcription factor TTF - 1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain."", DEVELOPMENT, (1991 DEC) 113 (4) 1093-104. JOURNAL CODE: ECW. ISSN: 0950-1991., ENGLAND: United Kingdom, XP002096753;;GUAZZI S ET AL: ""Thyroid nuclear factor 1 ( TTF - 1 ) contains a homeodomain and displays a novel DNA binding specificity."", EMBO JOURNAL, (1990 NOV) 9 (11) 3631-9. JOURNAL CODE: EMB. ISSN: 0261-4189., ENGLAND: United Kingdom, XP002096754;;BOHINSKI, ROBERT J. ET AL: ""Surfactant protein B gene promoter directs lung -specific gene expression and contains a complex nuclear protein binding site for thyroid transcription factor TTF - 1 and hepatocyte nuclear factor 3."", PEDIATRIC RESEARCH, VOL. 35, NO. 4 PART 2, PP. 326A. MEETING INFO.: 104TH ANNUAL MEETING OF THE AMERICAN PEDIATRIC SOCIETY AND THE 63RD ANNUAL MEETING OF THE SOCIETY FOR PEDIATRIC RESEARCH SEATTLE, WASHINGTON, USA MAY 2-5, 1994 ISSN: 0031-3998., XP002097520;;P. VAN RENTERGHEM ET AL.: ""Study of TTF-1 gene expression in dog thyrocytes in primary culture."", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 112, 1995, pages 83 - 93, XP002097521;;A. SAIARDI ET AL.: ""Cloning and sequence analysis of human thyroid transcription factor 1."", BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1261, 1995, pages 307 - 310, XP002097522;;H. OGUCHI ET AL.: ""The complete nucleotide sequenc of the mouse thyroid-specific enhance-binding protein (T/EBP) gene: extensive identity of the deduced amino acid sequence with the human protein."", BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1261, 1995, pages 304 - 306, XP002097523;;See also references of WO 9531729A1",DISCONTINUED
6,US,A,US 5976873 A,120-871-732-531-320,1999-11-02,1999,US 44280995 A,1995-05-17,US 44280995 A;;US 24535694 A,1994-05-18,Nucleic acid sequences controlling lung cell-specific gene expression,"An oligonucleotide which includes at least one nucleic acid sequence which binds to at least one nuclear protein found in lung cells, such as TTF-1 protein. The oligonucleotide may be contained in a vector. The at least one nuclear protein provides for lung cell-specific expression of the vector upon binding of the at least one nucleic acid sequence to the at least one nuclear protein. Such vector may also include genes encoding therapeutic agents, and may be employed for delivering genes encoding therapeutic agents to lung cells.",CHILDRENS HOSP MEDICAL CENTER,BOHINSKI ROBERT J;;WHITSETT JEFFREY A,CHILDREN'S HOSPITAL MEDICAL CENTER (1995-07-14),https://lens.org/120-871-732-531-320,Granted Patent,yes,3,8,7,7,76,A61K48/00;;C07K14/4705;;C07K14/785;;C12N15/85;;C12N15/86;;C12N2710/10343;;C12N2830/00;;C12N2830/008;;C12N2830/85;;Y10T428/2984;;Y10T428/2984;;C12N15/86;;C12N2830/008;;C12N2830/85;;A61K48/00;;C12N15/85;;C12N2710/10343;;C12N2830/00;;C07K14/785;;C07K14/4705,A61K48/00;;C07H21/04;;C07K14/47;;G01N33/566;;C07K14/785;;C12N15/00;;C12N15/09;;C12N15/85;;C12N15/861;;C12Q1/68;;C12R1/92,435/320.1;;536/24.1;;428/402.2,19,17,065-550-788-890-971;;063-469-288-339-138;;070-369-904-493-098;;019-143-354-676-998;;015-951-111-107-686;;073-205-060-172-152;;044-365-736-030-48X;;020-838-644-796-070;;078-718-750-967-476;;035-053-666-071-032;;015-951-111-107-686;;005-644-090-005-687;;070-369-904-493-098;;043-156-374-114-741;;018-096-680-842-036;;002-575-118-402-372;;040-030-407-962-50X,10.1089/dna.1.1989.8.75;;2924687;;1370653;;10.1016/0092-8674(92)90213-v;;8462742;;10.1006/dbio.1993.1090;;10.1042/bj3080197;;7755566;;pmc1136863;;10.1016/s0021-9258(18)42098-4;;1634515;;10.1093/nar/18.10.2939;;2349092;;pmc330822;;10.1042/bj3160467;;8687389;;pmc1217373;;pmc305010;;3035561;;10.1073/pnas.84.12.4007;;2839484;;10.1016/s0021-9258(19)81519-3;;1443158;;10.1152/ajplung.1992.263.5.l546;;10.1016/s0021-9258(18)42098-4;;1634515;;10.1128/mcb.12.2.576-588.1992;;pmc364231;;10.1128/mcb.12.2.576;;1732732;;8462742;;10.1006/dbio.1993.1090;;10.1016/s0021-9258(18)82105-6;;8496176;;pmc359916;;10.1128/mcb.13.7.3860-3871.1993;;8321193;;10.1128/mcb.13.7.3860;;10.1016/0953-7112(94)90043-4;;10.1089/hum.1994.5.1-29;;8155768;;8139574;;pmc358641;;10.1128/mcb.14.4.2755-2766.1994;;10.1128/mcb.14.4.2755,"Pilot Matias et al. Structure and organization of the gene encoding human pulmonary surfactant proteilpid SP B. DNA vol. 8 pp. 75 86, 1989.;;Rosenfeld et al. In vivo transter of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium Cell vol. 68 143 155, 1992.;;Wert et al. Transcriptional elements from the juman SP C gene direct expression in the primordial respiratory epithelium of transgenic mice. Dev. Biol. vol. 156 426 443, 1993.;;Bohinski et al. Therapeutic strategies for surfactant protein SP B deficiency. J. Cellular Biochem. Suppl. 17E Abstract SZ 400, p. 241, 1993.;;Bingle et al. Role of hepatocyte nuclear factor 3 alpha and hepatocyte nuclear factor 3 beta in clara cell secretory protein gene expression in the bronchiolar epithelium. Biochem. J. vol. 308 197 202, 1995.;;Stripp et al. cis acting elements that confer lung epithelial cell expression of the CC10 gene. J. Biol. Chem. vol. 267 14703 14712, 1992.;;Hagen et al. Tissue specific expression, hormonal regulation and 5 flanking gene region of the rat clara cell 10 kDa protein: comparison to rabbit uteroglobin. Nucleic Acids Research vol. 18 2939 2946, 1990.;;Toonen et al. The lung enriched transcription factor TTF 1 and the ubiquitously expressed proteins Sp1 and Sp3 interact with elements located in the minimal promoter of the rat clara cell secretory protein gene. Biochem. J. vol. 316 467 473, 1996.;;Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy, 1995.;;Glasser, et al., Proc. Natl. Acad. Sci. USA , vol. 84, pp. 4007 4011 (Jun. 1987).;;Glasser, et al., J. of Bio. Chem. , vol. 263, No. 21, pp. 10326 10331 (Jul. 25, 1988).;;Korfhagen, et al., Amer. Physiological Society , vol. 263 pp. L546 L554 (1992).;;Stripp, et al., J. of Bio. Chem. , vol. 267, No. 21, pp. 14703 14712 (Jul. 25, 1992).;;Francis Lang, et al., Molecular and Cellular Biology , vol. 12, No. 2, pp. 576 588 (Feb. 1992).;;Wert, et al., Developmental Biology , vol. 156, pp. 426 443 (1993).;;Bohinski, et al., J. of Bio. Chem. , vol. 268, No. 15, pp. 11160 11166 (May 25, 1993).;;Sawaya, et al., Molecular and Cellular Biology , vol. 13, No. 7, pp. 3860 3871 (Jul. 1993).;;Smith, et al., Human Gene Therapy , vol. 5, pp. 29 35 (1994).;;Overdier, et al., Molecular and Cellular Biology , vol. 14, No. 4, pp. 2755 2766 (Apr. 1994).",EXPIRED
7,EP,A1,EP 0763205 A1,031-433-205-252-382,1997-03-19,1997,EP 95921285 A,1995-05-17,US 9506244 W;;US 24535694 A,1994-05-18,NUCLEIC ACID SEQUENCES CONTROLLING LUNG CELL-SPECIFIC GENE EXPRESSION,,CHILDRENS HOSP MEDICAL CENTER,BOHINSKI ROBERT J;;WHITSETT JEFFREY A,,https://lens.org/031-433-205-252-382,Patent Application,yes,0,0,7,7,76,A61K48/00;;C07K14/4705;;C07K14/785;;C12N15/85;;C12N15/86;;C12N2710/10343;;C12N2830/00;;C12N2830/008;;C12N2830/85;;Y10T428/2984;;Y10T428/2984;;C12N15/86;;C12N2830/008;;C12N2830/85;;A61K48/00;;C12N15/85;;C12N2710/10343;;C12N2830/00;;C07K14/785;;C07K14/4705,A61K48/00;;C07H21/04;;C07K14/47;;C07K14/785;;C12N15/00;;C12N15/09;;G01N33/566;;C12N15/85;;C12N15/861;;C12Q1/68;;C12R1/92,,0,0,,,,DISCONTINUED
8,US,A,US 5614790 A,153-317-606-959-51X,1997-03-25,1997,US 48926495 A,1995-06-09,US 48926495 A,1995-06-09,Automatic alarm for fluorescent blinking,"Alarming mechanism, sounding and/or flashing, which signals fluorescent lamp malfunctioning as visibly manifested by flickering. The alarming mechanism according to this invention electrically engages the starter mechanism of a fluorescent lamp and is responsive to current change associated with abnormal flickering. Timely corrective action which is prompted by the alarm may avoid or mitigate one or more deleterious effects of such malfunctioning, such as energy waste, lamp damage, fire hazard and electronic interference. For many embodiments the alarming mechanism and the starter mechanism are advantageously coupled as a single structural unit.",US ARMY,FLECK SR CHARLES J;;BOHINSKI ROBERT A,NAVY DEPARTMENT OF UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SECRETARY (1995-06-07);;UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SECRETARY OF THE NAVY (1995-06-07),https://lens.org/153-317-606-959-51X,Granted Patent,yes,11,5,1,1,0,H05B47/20;;H05B47/20;;H05B47/28;;H05B47/28,H05B37/03,315/135;;315/105,10,1,091-834-154-956-980,10.1109/ee.1951.6436767,"Interfering Fluorescents, Popular Science, Sep. 1994, p. 50.;;Mischievous Fluorescents, Popular Science, 1995.;;Davidson, G.E., Flicker in Lighting Systems (Effect of Sudden Voltage Dips Studied), Ontario Hydro Research News, Oct. 1952, vol. 4, No. 4, pp. 9 11.;;Brieger, Lawrence, Effect of Voltage Dip Duration on Cyclic Light Flicker, Electrical Engineering, vol. 70, No. 8, Aug. 1951, pp. 685 689.;;Fox, Clifton S., Lamps, Luminous Tubes, and Other Noncoherent Electric Radiation Sources, Fink and Christiansen, Electric Engineers Handbook, 2nd Ed., McGraw Hill, New York, 1982, pp. 11 4 to 11 11.;;Markus, John, Modern Electronic Circuits Reference Manual, McGraw Hill, New York, 1980, ch. 44, pp. 489 494.;;Fink, Donald G., Beaty, H. Wayne, Standard Handbook for Electrical Engineers, Twelfth Ed., McGraw Hill, New York, 1987, pp. 26 17 to 26 23; pp. 26 70 to 26 71.;;Susskind, Charles, The Encyclopedia of Electronics, Reinhold Publishing Corp., New York, 1962, pp. 313 315.;;Eastman, Arthur A. and Campbell, John H., Stroboscopic and Flicker Effects from Fluorescent Lamps, Illuminating Engineering, Jan. 1952, pp. 27 35.;;Faucett, M.A. and Keener, C.A., Effects of Harmonics on Watthour Meter Accuracy, Electrical World, 27 Oct. 1945, pp. 82 84.",EXPIRED
9,BR,A2,BR PI1010924 A2,101-379-154-182-03X,2019-01-08,2019,BR PI1010924 A,2010-05-20,US 2010/0035582 W;;US 17992409 P,2009-05-20,retração montada em pacientes,,SYNTHES GMBH,BRIAN BANKOSKI;;MARK ROSSNEY;;RALPH C SOLITARIO;;ROBERT BOHINSKI;;SANTIAGO FIGUEREO,,https://lens.org/101-379-154-182-03X,Patent Application,no,0,0,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/02;;A61B17/34;;A61B17/70;;A61B17/88,,0,0,,,,DISCONTINUED
10,WO,A2,WO 2010/135537 A2,129-296-121-355-734,2010-11-25,2010,US 2010/0035582 W,2010-05-20,US 17992409 P,2009-05-20,PATIENT-MOUNTED RETRACTION,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for vayring procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",SYNTHES USA LLC;;SYNTHES GMBH;;SOLITARIO RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,SOLITARIO RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/129-296-121-355-734,Patent Application,yes,0,5,17,17,0,A61B17/3439;;A61B17/7035;;A61B2017/0256;;A61B2017/3419;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/7035;;A61B17/7091;;A61F2/442;;A61B2017/00477;;A61B2017/3419;;A61B2017/0256;;A61F2002/2835;;A61F2220/0025;;A61B17/3439;;A61B17/7035;;A61B2017/0256;;A61B2017/3419;;A61B17/3421,A61B17/34;;A61B17/02;;A61B17/70;;A61B17/88,,0,0,,,,PENDING
11,CN,A,CN 102497828 A,107-005-432-490-908,2012-06-13,2012,CN 201080027786 A,2010-05-20,US 2010/0035582 W;;US 17992409 P,2009-05-20,Patient-mounted retraction,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for vayring procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",SYNTHES USA LLC,SOLITARIO RALPH C;;BRIAN BANKOSKI;;MARK ROSSNEY;;SANTIAGO FIGUEREO;;ROBERT BOHINSKI,,https://lens.org/107-005-432-490-908,Patent Application,no,8,16,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34;;A61B17/02;;A61B17/70;;A61B17/88,,0,0,,,,ACTIVE
12,WO,A3,WO 2010/135537 A3,065-876-692-694-087,2011-01-20,2011,US 2010/0035582 W,2010-05-20,US 17992409 P,2009-05-20,PATIENT-MOUNTED RETRACTION,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type (102) and tube type (202) patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for vayring procedures and/or patient anatomies. Applications of re-positionable patient -mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",SYNTHES USA LLC;;SYNTHES GMBH;;SOLITARIO RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,SOLITARIO RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/065-876-692-694-087,Search Report,yes,6,0,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34;;A61B17/02;;A61B17/70;;A61B17/88,,0,0,,,,PENDING
13,KR,A,KR 20120028924 A,082-819-699-136-42X,2012-03-23,2012,KR 20117030012 A,2010-05-20,US 17992409 P;;US 2010/0035582 W,2009-05-20,PATIENT-MOUNTED RETRACTION,,SYNTHES GMBH,SOLITARIO RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/082-819-699-136-42X,Patent Application,no,0,1,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34;;A61B17/70;;A61B17/86,,0,0,,,,ACTIVE
14,CA,A1,CA 2762606 A1,059-617-161-685-604,2010-11-25,2010,CA 2762606 A,2010-05-20,US 17992409 P;;US 2010/0035582 W,2009-05-20,PATIENT-MOUNTED RETRACTION,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for vayring procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",SYNTHES USA LLC,SOLITARIO RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/059-617-161-685-604,Patent Application,no,0,0,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34;;A61B17/02;;A61B17/70,,0,0,,,,DISCONTINUED
15,US,A1,US 2011/0130634 A1,050-908-420-055-926,2011-06-02,2011,US 78405110 A,2010-05-20,US 78405110 A;;US 17992409 P,2009-05-20,PATIENT-MOUNTED RETRACTION,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for varying procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",SYNTHES USA LLC,SOLITARIO JR RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,DEPUY SPINE LLC (2012-12-30);;DEPUY SYNTHES PRODUCTS INC (2012-12-30);;SYNTHES USA LLC (2010-07-16),https://lens.org/050-908-420-055-926,Patent Application,yes,117,89,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B1/32,600/231,0,0,,,,ACTIVE
16,US,A1,US 2021/0212723 A1,189-980-991-077-19X,2021-07-15,2021,US 202117213457 A,2021-03-26,US 202117213457 A;;US 201715654827 A;;US 78405110 A;;US 17992409 P,2009-05-20,Patient-Mounted Retraction,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for vayring procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating envrionment.",DEPUY SYNTHES PRODUCTS INC,SOLITARIO RALPH C;;BANKOSKI BRIAN R;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/189-980-991-077-19X,Patent Application,yes,0,0,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34,,0,0,,,,PENDING
17,US,B2,US 9808281 B2,189-887-547-350-894,2017-11-07,2017,US 78405110 A,2010-05-20,US 78405110 A;;US 17992409 P,2009-05-20,Patient-mounted retraction,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for varying procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",SOLITARIO JR RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT;;DEPUY SYNTHES PRODUCTS INC,SOLITARIO JR RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,DEPUY SPINE LLC (2012-12-30);;DEPUY SYNTHES PRODUCTS INC (2012-12-30);;SYNTHES USA LLC (2010-07-16),https://lens.org/189-887-547-350-894,Granted Patent,yes,585,6,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/70;;A61B17/02;;A61B17/34,,18,5,029-951-402-088-364;;044-923-049-931-888;;047-153-884-575-240;;151-671-594-152-880;;029-951-402-088-364,10.1227/00006123-200007000-00019;;10.1097/00006123-200007000-00019;;10917351;;10.3171/foc.2004.16.1.14;;15264791;;10.1016/s1074-3804(05)80175-6;;9050697;;10.1097/00007632-198806000-00019;;3175760;;10.1227/00006123-200007000-00019;;10.1097/00006123-200007000-00019;;10917351,"“Xia Spinal System”, Stryker Howmedica Osteonics, 1999,8 pages.;;Aperture™, “Spinal Access System”, DePuy AcroMed, 2003, 6 pages.;;Atavi™, “Atraumatic Spine Fusion System—Endoscopic Posterolateral Fusion”, Endius, 2001, 10 pages.;;Branch et al., “Tangent: Posterior Impacted Instrument Set Technique”, Medtronic Sofamor Danek, 2000, 17 pages.;;Foley et al., “Cd Horizon Sextant Rod Insertion System Surgical Technique”, Medtronic Sofamor Danek, 2002, 30 pages.;;Harms, “Polyaxial Reduction Screw: Surgical Technique”, Depuy AcroMed, 1998, 13 pages.;;Hilton et al., “Metrx: Microdiscectomy Surgical Technique”, Medtronic Sofamor Danek, 2002, 20 pages.;;Kambin, “The Role of Minimally Invasive Surgery in Spinal Disorders”, Advances in Operative Orthopedics, 1995, 3, 147-171.;;Muller et al., “Techniques and Applications : A Keyhole Approach for Endoscopically assisted Pedicle Screw Fixation in Lumbar Spine Inability”, Jul. 2000 Neurosurgery, 47(1), 11 pages.;;Synthes Spine, “Constellation CP System: A Minimally Invasive System for use with Cannulated Pangea”, Technique Guide, Synthes Spinem, 2008, 42 pages.;;Thongtrangan et al., “Minimally Invasive Spinal Surgery: A Historical Perspective”, Neurosurg Focus, Jan. 2004, 16(1), article 13, 9 pages.;;Turner et al., “A New Radially Expanding Access System for Laparoscopic Procedures versus Conventional Cannulas”, The Journal of the American Association of Gynecologic Laparoscopists, Aug. 1996, 3(4), 7 pages.;;Wiltse et al., “New Uses and Refinements of the Paraspinal Approach to the Lumbar Spine” Jan. 18, 1988, 22 pages.;;Viper 2 System Guide, DePuy Spine, 2011, 60 pages.;;Synthes Spine, “USS Fracture System: Technique Guide”, 2001, 20 pages.;;Muller, et al., “A Keyhole Approach for Endoscopically Assisted Pedicle Screw Fixation in Lumbar Spine Instability [Techniques and Applications]”, Department of Neurosurgery, 18 pages, Received, Sep. 14, 1999, Accepted Mar. 2, 2000.;;Matrix Spine System—Deformity Technique Guide, “A Posterior Pedicle Screw, Hook, and Rod Fixation System,” Synthes, copyrights 2010, 75 pages.;;International Patent Application No. PCT/US2007/066469: International Search Report dated Aug. 1, 2008, 6 pages.",ACTIVE
18,EP,A2,EP 2432407 A2,046-058-938-844-652,2012-03-28,2012,EP 10720857 A,2010-05-20,US 2010/0035582 W;;US 17992409 P,2009-05-20,PATIENT-MOUNTED RETRACTOR,,SYNTHES GMBH,SOLITARIO J R RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/046-058-938-844-652,Patent Application,yes,0,0,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34;;A61B17/02;;A61B17/70;;A61B17/88,,1,0,,,See references of WO 2010135537A2,ACTIVE
19,US,B2,US 10993739 B2,067-815-228-437-830,2021-05-04,2021,US 201715654827 A,2017-07-20,US 201715654827 A;;US 78405110 A;;US 17992409 P,2009-05-20,Patient-mounted retraction,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for varying procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",DEPUY SYNTHES PRODUCTS INC,SOLITARIO JR RALPH C;;BANKOSKI BRIAN R;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/067-815-228-437-830,Granted Patent,yes,620,0,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/02;;A61B17/34;;A61B17/70,,18,5,151-671-594-152-880;;047-153-884-575-240;;044-923-049-931-888;;029-951-402-088-364;;029-951-402-088-364,10.1097/00007632-198806000-00019;;3175760;;10.1016/s1074-3804(05)80175-6;;9050697;;10.3171/foc.2004.16.1.14;;15264791;;10.1227/00006123-200007000-00019;;10.1097/00006123-200007000-00019;;10917351;;10.1227/00006123-200007000-00019;;10.1097/00006123-200007000-00019;;10917351,"Wiltse et al., “New Uses and Refinements of the Paraspinal Approach to the Lumbar Spine” Jan. 18, 1988, 22 pages.;;Viper 2 System Guide, DePuy Spine, 2011, 60 pages.;;Turner et al., “A New Radially Expanding Access System for Laparoscopic Procedures versus Conventional Cannulas”, The Journal of the American Association of Gynecologic Laparoscopists, Aug. 1996, 3(4), 7 pages.;;Thongtrangan et al., “Minimally Invasive Spinal Surgery: A Historical Perspective”, Neurosurg Focus, Jan. 2004, 16(1), article 13, 9 pages.;;Synthes Spine, “USS Fracture System: Technique Guide”, 2001, 20 pages.;;Synthes Spine, “Constellation CP System: A Minimally Invasive System for use with Cannulated Pangea”, Technique Guide, Synthes Spinem, 2008, 42 pages.;;Muller, et al., “A Keyhole Approach for Endoscopically Assisted Pedicle Screw Fixation in Lumbar Spine Instability [Techniques and Applications]”, Department of Neurosurgery, 18 pages, Accepted Mar. 2, 2000.;;Muller et al., “Techniques and Applications : A Keyhole Approach for Endoscopically assisted Pedicle Screw Fixation in Lumbar Spine Inability”, Jul. 2000 Neurosurgery, 47(1), 11 pages.;;Matrix Spine System—Deformity Technique Guide, “A Posterior Pedicle Screw, Hook, and Rod Fixation System,” Synthes, copyrights 2010, 75 pages.;;Kambin, “The Role of Minimally Invasive Surgery in Spinal Disorders”, Advances in Operative Orthopedics, 1995, 3, 147-171.;;International Patent Application No. PCT/US2007/066469: International Search Report dated Aug. 1, 2008, 6 pages.;;Hilton et al., “Metrx: Microdiscectomy Surgical Technique”, Medtronic Sofamor Danek, 2002, 20 pages.;;Harms; Moss Miami, “Polyaxial Reduction Screw; Surgical Technique”, DePuy AcroMed; 13 pages, 1998.;;Foley et al., “Cd Horizon Sextant Rod Insertion System Surgical Technique”, Medtronic Sofamor Danek, 2002, 30 pages.;;Branch et al., “Tangent: Posterior Impacted Instrument Set Technique”, Medtronic Sofamor Danek, 2000, 17 pages.;;Atavi Trademark, “Atraumatic Spine Fusion System—Endoscopic Posterolateral Fusion”, Endius, 2001, 10 pages.;;Aperture Trademark, “Spinal Access System”, DePuy AcroMed, 2003, 6 pages.;;“Xia Spinal System”, Stryker Howmedica Osteonics, 1999,8 pages.",ACTIVE
20,EP,B1,EP 2432407 B1,194-355-702-389-304,2013-04-17,2013,EP 10720857 A,2010-05-20,US 2010/0035582 W;;US 17992409 P,2009-05-20,PATIENT-MOUNTED RETRACTOR,,SYNTHES GMBH,SOLITARIO J R RALPH C;;BANKOSKI BRIAN;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/194-355-702-389-304,Granted Patent,yes,6,0,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34;;A61B17/02;;A61B17/70;;A61B17/88,,0,0,,,,ACTIVE
21,US,A1,US 2017/0311980 A1,118-655-882-694-67X,2017-11-02,2017,US 201715654827 A,2017-07-20,US 201715654827 A;;US 78405110 A;;US 17992409 P,2009-05-20,PATIENT-MOUNTED RETRACTION,"Patient-mounted retractors with varying configurations and/or features are provided, along with additional components for use therewith in provided patient-mounted retractor assemblies. Blade type and tube type patient-mounted retractors that may be re-positioned during the course of a procedure are provided in varying configurations and/or geometries suitable for varying procedures and/or patient anatomies. Applications of re-positionable patient-mounted retractor assemblies are particularly suitable for use in minimally invasive procedures, eliminating the need for table-mounted retraction assemblies and/or cannulas that restrict the operating environment.",DEPUY SYNTHES PRODUCTS INC,SOLITARIO JR RALPH C;;BANKOSKI BRIAN R;;ROSSNEY MARK;;FIGUEREO SANTIAGO;;BOHINSKI ROBERT,,https://lens.org/118-655-882-694-67X,Patent Application,yes,9,6,17,17,0,A61B17/3421;;A61B17/3421;;A61B17/3421;;A61B17/3439;;A61B17/3439;;A61B17/3439;;A61B17/7035;;A61B17/7035;;A61B17/7035;;A61B17/7091;;A61B2017/00477;;A61B2017/0256;;A61B2017/0256;;A61B2017/0256;;A61B2017/3419;;A61B2017/3419;;A61B2017/3419;;A61F2/442;;A61F2002/2835;;A61F2220/0025,A61B17/34;;A61B17/02;;A61B17/70,,0,0,,,,ACTIVE
